Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.
about
Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary DysplasiaPostnatal inflammation in the pathogenesis of bronchopulmonary dysplasiaRepeated β2-adrenergic receptor agonist therapy attenuates the response to rescue bronchodilation in a hyperoxic newborn mouse model.Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structureDynamic regulation of platelet-derived growth factor receptor α expression in alveolar fibroblasts during realveolarizationNeonatal oxygen exposure alters airway hyper-responsiveness but not the response to allergen challenge in adult mice.Adiponectin protects against hyperoxic lung injury and vascular leakNox2-derived ROS in PPARγ signaling and cell-cycle progression of lung alveolar epithelial cells.S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia.Balancing anti-inflammatory and anti-oxidant responses in murine bone marrow derived macrophages.Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension.Impaired alveolarization and intra-uterine growth restriction in rats: a postnatal genome-wide analysis.Rosiglitazone inhibits PM2.5-induced cytotoxicity in human lung epithelial A549 cells.
P2860
Q26770515-DE32BCCA-7349-46DE-961C-E1D20E874469Q33622213-B8BEABAB-C0D8-4CF5-86B1-817824150CA9Q34051397-2B5F5E27-4B96-4BF4-8FAE-58C07BDB711FQ34669226-DE29FE3B-7F78-485D-979C-20FE9315F77BQ36369940-701ADCE3-22A7-4328-A8E1-47749A2F9837Q37685444-7AD5DC34-B1A4-4DDD-8F6D-53AFE53CD66FQ37723787-55DAE6AD-EE04-4C0C-A0C4-210CC725413CQ39526488-86C780C5-F7AD-47BC-AF9F-E161523F3AEDQ39533224-9B02EB58-E798-44E8-B293-C0459FD76451Q41491342-B934ECF1-2C6E-49CC-9193-9F3DA59BAEDAQ41943805-4BB77F1B-4A12-47E2-BE8A-82F89CC5342EQ50626594-A2D31479-7F96-4D39-A06A-EB023A08D48BQ55495015-D84EE480-A3A1-4B2A-9FA9-278DDF772DBB
P2860
Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Peroxisome proliferator-activa ...... neonatal chronic lung disease.
@ast
Peroxisome proliferator-activa ...... neonatal chronic lung disease.
@en
type
label
Peroxisome proliferator-activa ...... neonatal chronic lung disease.
@ast
Peroxisome proliferator-activa ...... neonatal chronic lung disease.
@en
prefLabel
Peroxisome proliferator-activa ...... neonatal chronic lung disease.
@ast
Peroxisome proliferator-activa ...... neonatal chronic lung disease.
@en
P2093
P2860
P356
P1476
Peroxisome proliferator-activa ...... neonatal chronic lung disease
@en
P2093
E Nozik-Grayck
E W Gelfand
K R Stenmark
M Armstrong
P2860
P304
P356
10.1002/AR.20921
P577
2009-07-01T00:00:00Z